Patents Assigned to HANGZHOU ZHENGXIANG PHARMACEUTICALS CO., LTD.
  • Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
    Patent number: 10792283
    Abstract: The present disclosure provides selective phosphoinositide 3-kinase inhibitors of formula (A), or pharmaceutically acceptable salts thereof. These compounds are useful for the treatment of conditions mediated by one or more P13K isoforms, such as PI3K delta (PI3K?). The present disclosure further provides methods of inhibiting phosphoinositide 3-kinase inhibitors using these compounds for treatment of disorders related to phosphatidylinositol 3-kinase activity.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: October 6, 2020
    Assignee: HANGZHOU ZHENGXIANG PHARMACEUTICALS CO., LTD.
    Inventor: Xiaolin Hao
  • QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
    Publication number: 20190365752
    Abstract: The present disclosure provides selective phosphoinositide 3-kinase inhibitors of formula (A), or pharmaceutically acceptable salts thereof. These compounds are useful for the treatment of conditions mediated by one or more P13K isoforms, such as PI3K delta (PI3K?). The present disclosure further provides methods of inhibiting phosphoinositide 3-kinase inhibitors using these compounds for treatment of disorders related to phosphatidylinositol 3-kinase activity.
    Type: Application
    Filed: February 28, 2017
    Publication date: December 5, 2019
    Applicant: HANGZHOU ZHENGXIANG PHARMACEUTICALS CO., LTD.
    Inventor: Xiaolin HAO